Skip to main content
Top
Published in:

07-12-2024 | Adrenalectomy | Original Article

Outcomes after adrenalectomy in elderly patients; a propensity score matched analysis

Authors: Charlotte L. Viëtor, Inge S. van Egmond, Gaston J. H. Franssen, Cornelis Verhoef, Richard A. Feelders, Tessa M. van Ginhoven

Published in: Updates in Surgery | Issue 1/2025

Login to get access

Abstract

Adrenal masses are being found more and more often over the years. Given the association of these masses with advancing age, the decision to perform surgery in older, sometimes asymptomatic patients presents a clinical dilemma. These patients are potentially more vulnerable to adverse postoperative outcomes due to increased frailty. Therefore, this study aimed to compare the postoperative course after adrenalectomy in patients aged 70 years and older to that of a younger cohort. This single center retrospective study included patients aged ≥ 70 years who underwent adrenalectomy between 2000–2020, and propensity-score matched younger patients (< 70 years). Patients were matched based on hormonal overproduction, malignant diagnosis, surgical approach and year of surgery. The study included 77 elderly patients (median age 74 years) and 77 younger patients (median age 52 years; p < 0.001). Serious complications (Clavien–Dindo ≥ 3) occurred in 9.1% of elderly patients and 6.5% of the matched younger cohort (p = 0.773). The overall complication rate was 44.2% in elderly and 40.3% in younger patients (p = 0.771), with similar duration of hospital admission and mortality in both groups. Elderly patients experienced mostly infectious (33.8%) or cardiovascular complications (27.0%), and cardiovascular complications were more frequent in elderly than in younger patients (6.7%, p = 0.039). In conclusion, patients aged 70 years and older who undergo adrenalectomy have a similar postoperative course and complication rate as younger patients, with most postoperative complications being minor, and mortality being minimal. Therefore, older age itself should not be a reason to refrain from adrenalectomy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hedeland H et al (1968) On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand 184:211–214CrossRefPubMed Hedeland H et al (1968) On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand 184:211–214CrossRefPubMed
2.
go back to reference Ebbehoj A et al (2020) Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study. Lancet Diabetes Endocrinol 8:894–902CrossRefPubMedPubMedCentral Ebbehoj A et al (2020) Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study. Lancet Diabetes Endocrinol 8:894–902CrossRefPubMedPubMedCentral
3.
go back to reference Jing Y et al (2022) Prevalence and characteristics of adrenal tumors in an unselected screening population: a cross-sectional study. Ann Intern Med 175:1383–1391CrossRefPubMed Jing Y et al (2022) Prevalence and characteristics of adrenal tumors in an unselected screening population: a cross-sectional study. Ann Intern Med 175:1383–1391CrossRefPubMed
4.
go back to reference Song JH et al (2008) The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol 190:1163–1168CrossRefPubMed Song JH et al (2008) The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol 190:1163–1168CrossRefPubMed
5.
go back to reference Sconfienza E et al (2023) Prevalence of functioning adrenal incidentalomas: a systematic review and meta-analysis. J Clin Endocrinol Metab 108:1813–1823CrossRefPubMed Sconfienza E et al (2023) Prevalence of functioning adrenal incidentalomas: a systematic review and meta-analysis. J Clin Endocrinol Metab 108:1813–1823CrossRefPubMed
6.
go back to reference Fassnacht M et al (2023) European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 189:G1–G42CrossRefPubMed Fassnacht M et al (2023) European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 189:G1–G42CrossRefPubMed
7.
go back to reference Lee JM et al (2017) Clinical guidelines for the management of adrenal incidentaloma. Endocrinol Metab (Seoul) 32:200–218CrossRefPubMed Lee JM et al (2017) Clinical guidelines for the management of adrenal incidentaloma. Endocrinol Metab (Seoul) 32:200–218CrossRefPubMed
8.
go back to reference Fassnacht M et al (2018) European Society of Endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 179:G1–G46CrossRefPubMed Fassnacht M et al (2018) European Society of Endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 179:G1–G46CrossRefPubMed
9.
go back to reference Feelders RA et al (2019) Advances in the medical treatment of Cushing’s syndrome. Lancet Diabetes Endocrinol 7:300–312CrossRefPubMed Feelders RA et al (2019) Advances in the medical treatment of Cushing’s syndrome. Lancet Diabetes Endocrinol 7:300–312CrossRefPubMed
10.
go back to reference Collard RM et al (2012) Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc 60:1487–1492CrossRefPubMed Collard RM et al (2012) Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc 60:1487–1492CrossRefPubMed
11.
go back to reference Polanczyk CA et al (2001) Impact of age on perioperative complications and length of stay in patients undergoing noncardiac surgery. Ann Intern Med 134:637–643CrossRefPubMed Polanczyk CA et al (2001) Impact of age on perioperative complications and length of stay in patients undergoing noncardiac surgery. Ann Intern Med 134:637–643CrossRefPubMed
12.
go back to reference Panayi AC et al (2019) Impact of frailty on outcomes in surgical patients: a systematic review and meta-analysis. Am J Surg 218:393–400CrossRefPubMed Panayi AC et al (2019) Impact of frailty on outcomes in surgical patients: a systematic review and meta-analysis. Am J Surg 218:393–400CrossRefPubMed
13.
go back to reference von Elm E et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453–1457CrossRef von Elm E et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453–1457CrossRef
14.
go back to reference Charlson ME et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRefPubMed Charlson ME et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRefPubMed
15.
go back to reference Dindo D et al (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral Dindo D et al (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral
17.
go back to reference Murphy MM et al (2010) Trends in adrenalectomy: a recent national review. Surg Endosc 24:2518–2526CrossRefPubMed Murphy MM et al (2010) Trends in adrenalectomy: a recent national review. Surg Endosc 24:2518–2526CrossRefPubMed
18.
go back to reference Weinandt M et al (2017) Laparoscopic adrenalectomy in elderly patients. Surg Laparosc Endosc Percutan Tech 27:e132–e135CrossRefPubMed Weinandt M et al (2017) Laparoscopic adrenalectomy in elderly patients. Surg Laparosc Endosc Percutan Tech 27:e132–e135CrossRefPubMed
19.
go back to reference Ahuja V et al (2024) Impact of frailty on complications and length of stay after minimally invasive adrenalectomy surgery. Surgery 175:336–341CrossRefPubMed Ahuja V et al (2024) Impact of frailty on complications and length of stay after minimally invasive adrenalectomy surgery. Surgery 175:336–341CrossRefPubMed
20.
21.
go back to reference Kazaure HS et al (2011) Adrenalectomy in older Americans has increased morbidity and mortality: an analysis of 6,416 patients. Ann Surg Oncol 18:2714–2721CrossRefPubMed Kazaure HS et al (2011) Adrenalectomy in older Americans has increased morbidity and mortality: an analysis of 6,416 patients. Ann Surg Oncol 18:2714–2721CrossRefPubMed
22.
go back to reference Fouche D et al (2023) Risk factors for intraoperative complications, postoperative complications, and prolonged length of stay after laparoscopic adrenalectomy by transperitoneal lateral approach: a retrospective cohort study of 547 procedures. Surg Endosc 37:7573–7581CrossRefPubMed Fouche D et al (2023) Risk factors for intraoperative complications, postoperative complications, and prolonged length of stay after laparoscopic adrenalectomy by transperitoneal lateral approach: a retrospective cohort study of 547 procedures. Surg Endosc 37:7573–7581CrossRefPubMed
24.
go back to reference Srougi V et al (2016) Presentation and surgery outcomes in elderly with pheocromocytoma: a comparative analysis with Young patients. Int Braz J Urol 42:671–677CrossRefPubMedPubMedCentral Srougi V et al (2016) Presentation and surgery outcomes in elderly with pheocromocytoma: a comparative analysis with Young patients. Int Braz J Urol 42:671–677CrossRefPubMedPubMedCentral
25.
go back to reference Lo CY et al (1996) Adrenal surgery in the elderly: too risky? World J Surg 20:368–373 (discussion 74)CrossRefPubMed Lo CY et al (1996) Adrenal surgery in the elderly: too risky? World J Surg 20:368–373 (discussion 74)CrossRefPubMed
26.
go back to reference Gaujoux S et al (2017) European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma. Br J Surg 104:358–376CrossRefPubMed Gaujoux S et al (2017) European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma. Br J Surg 104:358–376CrossRefPubMed
27.
go back to reference Marano L et al (2022) Handgrip strength predicts length of hospital stay in an abdominal surgical setting: the role of frailty beyond age. Aging Clin Exp Res 34:811–817CrossRefPubMedPubMedCentral Marano L et al (2022) Handgrip strength predicts length of hospital stay in an abdominal surgical setting: the role of frailty beyond age. Aging Clin Exp Res 34:811–817CrossRefPubMedPubMedCentral
28.
go back to reference Theou O et al (2012) Disability and co-morbidity in relation to frailty: how much do they overlap? Arch Gerontol Geriatr 55:e1-8CrossRefPubMed Theou O et al (2012) Disability and co-morbidity in relation to frailty: how much do they overlap? Arch Gerontol Geriatr 55:e1-8CrossRefPubMed
29.
go back to reference Hoogendijk EO et al (2019) Frailty: implications for clinical practice and public health. Lancet 394:1365–1375CrossRefPubMed Hoogendijk EO et al (2019) Frailty: implications for clinical practice and public health. Lancet 394:1365–1375CrossRefPubMed
30.
go back to reference Li J et al (2020) Laparoscopic adrenalectomy (LA) vs open adrenalectomy (OA) for pheochromocytoma (PHEO): a systematic review and meta-analysis. Eur J Surg Oncol 46:991–998CrossRefPubMed Li J et al (2020) Laparoscopic adrenalectomy (LA) vs open adrenalectomy (OA) for pheochromocytoma (PHEO): a systematic review and meta-analysis. Eur J Surg Oncol 46:991–998CrossRefPubMed
31.
go back to reference Parente A et al (2023) Risk factors for postoperative complications after adrenalectomy for phaeochromocytoma: multicentre cohort study. BJS Open 7(5), zrad090 Parente A et al (2023) Risk factors for postoperative complications after adrenalectomy for phaeochromocytoma: multicentre cohort study. BJS Open 7(5), zrad090
32.
go back to reference Shahait A et al (2022) Two decades’ outcomes and trends of adrenalectomy for benign pathologies in veterans. Surg Laparosc Endosc Percutan Tech 32:736–740CrossRefPubMed Shahait A et al (2022) Two decades’ outcomes and trends of adrenalectomy for benign pathologies in veterans. Surg Laparosc Endosc Percutan Tech 32:736–740CrossRefPubMed
33.
go back to reference He J et al (2023) Establishment and validation of a nomogram for predicting perioperative complications of retroperitoneal laparoscopic adrenalectomy. Transl Androl Urol 12:572–585CrossRefPubMedPubMedCentral He J et al (2023) Establishment and validation of a nomogram for predicting perioperative complications of retroperitoneal laparoscopic adrenalectomy. Transl Androl Urol 12:572–585CrossRefPubMedPubMedCentral
Metadata
Title
Outcomes after adrenalectomy in elderly patients; a propensity score matched analysis
Authors
Charlotte L. Viëtor
Inge S. van Egmond
Gaston J. H. Franssen
Cornelis Verhoef
Richard A. Feelders
Tessa M. van Ginhoven
Publication date
07-12-2024
Publisher
Springer International Publishing
Published in
Updates in Surgery / Issue 1/2025
Print ISSN: 2038-131X
Electronic ISSN: 2038-3312
DOI
https://doi.org/10.1007/s13304-024-02043-7
SPONSORED

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by:
  • Viatris
Developed by: Springer Healthcare
Watch now
Video